Nina Abide | FetalFirst Featured in Forbes France: How AI Is Redefining Prenatal Diagnosis

Forbes France BrandVoice – Published 28 October 2025

Nina Abide, Founder & CEO of FetalFirst, interviewed on Forbes France BrandVoice about AI in prenatal diagnosis.

READ ON FORBES.FR
Televised Interview

Forbes France spotlights FetalFirst and founder Nina Abide in a televised feature on how artificial intelligence is combining medical precision, empathy, and accessibility to transform prenatal care.

In this televised Forbes France interview, Nina Abide, founder and CEO of FetalFirst, discusses how artificial intelligence is reshaping prenatal diagnosis by bringing together medical precision, ethical innovation, and human empathy.

The feature highlights FetalFirst’s ongoing collaborations with the NHS, Imperial College Healthcare, and the University of Oxford, as well as its mission to empower both clinicians and parents through secure, data-driven insights.

Published in October 2025, the story marks an important milestone in FetalFirst’s journey to make fetal medicine more connected, inclusive, and human.

 

Key Quotes

AI doesn’t replace humans — it empowers them.
— Nina Abide
By merging AI and empathy, FetalFirst gives parents clarity when they need it most.
— Forbes France
This isn’t just a technological leap — it’s an ethical advancement.
— Forbes France
 

What Forbes Featured

  • From lived experience to innovation: how FetalFirst emerged from a gap in fetal medicine.

  • AI-driven diagnostic support validated

  • Clinical validation under NHS REC approval and ClinicalTrials.gov registration.

  • 98.2% negative predictive value achieved in early feasibility testing.

  • Dual mission: empowering clinicians with real-time AI insights and supporting parents with guidance and telehealth.

  • Global expansion to Europe and the Middle East.

  • Built on a foundation of data ethics, privacy, and empathy.

 

Watch: The Story Behind FetalFirst

From Personal Mission to Clinical Validation — How FetalFirst Is Transforming Prenatal Diagnosis


Media Kit & Assets

For journalists, collaborators, and event organisers:

Press Release — Official announcement of the Forbes France feature

Video Package — High-definition interview clips and transcripts

Brand Assets — Logos, founder headshots

Fact Sheet — Key metrics, milestones, and partnerships

Founder Bio — Nina Abide’s background and mission statement

Email: info@fetalfirst.com
Phone: +44 3488 7728
LinkedIn: https://www.linkedin.com/company/fetalfirst

Nina Abide, CEO & Founder
Available for interviews, podcasts, and speaking engagements

Response time: Within 24 hours


© 2025 Forbes Media & FetalFirst. All rights reserved. Unauthorized distribution or editing prohibited.

Next
Next

Nina Abide: From Personal Loss to FetalFirst – Full Founder Interview